Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 4
1999 2
2001 2
2003 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
Improved iodine radiolabels for monoclonal antibody therapy.
Stein R, Govindan SV, Mattes MJ, Chen S, Reed L, Newsome G, McBride BJ, Griffiths GL, Hansen HJ, Goldenberg DM. Stein R, et al. Cancer Res. 2003 Jan 1;63(1):111-8. Cancer Res. 2003. PMID: 12517786 Free article.
Successful therapy of a human lung cancer xenograft using MAb RS7 labeled with residualizing radioiodine.
Stein R, Govindan SV, Chen S, Reed L, Spiegelman H, Griffiths GL, Hansen HJ, Goldenberg DM. Stein R, et al. Crit Rev Oncol Hematol. 2001 Jul-Aug;39(1-2):173-80. doi: 10.1016/s1040-8428(01)00106-8. Crit Rev Oncol Hematol. 2001. PMID: 11418314
Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22.
Sharkey RM, Behr TM, Mattes MJ, Stein R, Griffiths GL, Shih LB, Hansen HJ, Blumenthal RD, Dunn RM, Juweid ME, Goldenberg DM. Sharkey RM, et al. Cancer Immunol Immunother. 1997 May;44(3):179-88. doi: 10.1007/s002620050371. Cancer Immunol Immunother. 1997. PMID: 9191878
Targeting human cancer xenografts with monoclonal antibodies labeled using radioiodinated, diethylenetriaminepentaacetic acid-appended peptides.
Stein R, Govindan SV, Mattes MJ, Shih LB, Griffiths GL, Hansen HJ, Goldenberg DM. Stein R, et al. Clin Cancer Res. 1999 Oct;5(10 Suppl):3079s-3087s. Clin Cancer Res. 1999. PMID: 10541347
Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: evaluation of (177)Lu and comparison of its efficacy with that of (90)Y and residualizing (131)I.
Stein R, Govindan SV, Chen S, Reed L, Richel H, Griffiths GL, Hansen HJ, Goldenberg DM. Stein R, et al. J Nucl Med. 2001 Jun;42(6):967-74. J Nucl Med. 2001. PMID: 11390564 Free article.
Advantage of yttrium-90-labeled over iodine-131-labeled monoclonal antibodies in the treatment of a human lung carcinoma xenograft.
Stein R, Chen S, Haim S, Goldenberg DM. Stein R, et al. Cancer. 1997 Dec 15;80(12 Suppl):2636-41. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2636::aid-cncr39>3.3.co;2-n. Cancer. 1997. PMID: 9406718
Feedback